These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3087226)

  • 41. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
    István L; Bariska I; Marton E
    Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
    [No Abstract]   [Full Text] [Related]  

  • 42. Surgical management of musculoskeletal problems in hemophilia.
    Wilson FC; Mahew DE; McMillan CW
    Instr Course Lect; 1983; 32():233-41. PubMed ID: 6443731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful use of ReFacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery.
    Sennett MM; de Alarcón PA
    Haemophilia; 2004 Sep; 10(5):655-60. PubMed ID: 15357792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experience with prophylaxis in Sweden.
    Nilsson IM
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
    [No Abstract]   [Full Text] [Related]  

  • 45. Open synovectomy for the prevention of recurrent hemarthrosis of the ankle in patients with hemophilia. A report of five cases with magnetic resonance imaging documentation.
    Plazanet F; du Boullay C; Defaux F; Dirat G; Ayache N; Azais I; Debiais F; Alcalay M
    Rev Rhum Engl Ed; 1997 Mar; 64(3):166-71. PubMed ID: 9090765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of synovectomy in the management of a target joint.
    Llinás A
    Haemophilia; 2008 Jul; 14 Suppl 3():177-80. PubMed ID: 18510539
    [No Abstract]   [Full Text] [Related]  

  • 47. Radioactive synoviorthesis in patients with hemophilia with factor inhibitor.
    Löfqvist T; Petersson C; Nilsson IM
    Clin Orthop Relat Res; 1997 Oct; (343):37-41. PubMed ID: 9345203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management of patients with bleeding disorders.
    Wyld PJ; Dawson KP
    N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072
    [No Abstract]   [Full Text] [Related]  

  • 50. [Recent findings on hemophilia].
    Abe T; Kinoshita T
    Nihon Rinsho; 1981; 39(12):3647-56. PubMed ID: 6803031
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemophilic arthropathy.
    Hilgartner MW
    Adv Pediatr; 1974; 21():139-65. PubMed ID: 4614656
    [No Abstract]   [Full Text] [Related]  

  • 53. Medical and surgical management of intracranial bleeding in hemophilic children.
    Carrea R; Pavlovsky A; Monges J; Tezanos Pinto M; Penchansky L
    Acta Neurol Latinoam; 1968; 14(1):155-73. PubMed ID: 5757591
    [No Abstract]   [Full Text] [Related]  

  • 54. [Dose option of haemophilia prophylaxis in children].
    Tang L; Wu RH
    Zhonghua Er Ke Za Zhi; 2012 Jan; 50(1):70-2. PubMed ID: 22456080
    [No Abstract]   [Full Text] [Related]  

  • 55. Dose and outcome of care in haemophilia--how do we define cost-effectiveness?
    Fischer K; Van den Berg HM; Thomas R; Kumar S; Poonnoose P; Viswabandya A; Mathews V; Kavitha ML; Bhattacharji S; Srivastava A
    Haemophilia; 2004 Oct; 10 Suppl 4():216-20. PubMed ID: 15479401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Suppression of factor VIII inhibitor in children with hemophilia A].
    Zenz W; Muntean W
    Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rheumatological management of patients with hemophilia. Part 1: joint manifestations.
    Alcalay M; Deplas A
    Joint Bone Spine; 2002 Oct; 69(5):442-9. PubMed ID: 12477227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Future aspects of hemophilia research and care.
    Valentino LA; Scheiflinger F
    Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():32-8. PubMed ID: 16804834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor VIII inhibitor treatment with high doses of F VIII.
    Stenbjerg S; Ingerslev J; Zachariae E
    Thromb Res; 1984 Jun; 34(6):533-9. PubMed ID: 6429891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy.
    Hutchinson RJ; Penner JA; Hensinger RN
    Pediatrics; 1983 Apr; 71(4):631-3. PubMed ID: 6601258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.